$ASPI: ASP Isotopes Inc. - Common Stock

ASP Isotopes Inc. (ASPI) is a pre-commercial stage advanced materials company that focuses on the production of high value and low volume isotopes for medical, nuclear power, and other industries. The company serves customers worldwide.

ASPI's isotopes are used in a variety of applications, including:

• Medical: ASP isotopes are used in the development and production of medical imaging agents, cancer treatments, and other medical devices.
• Nuclear power: ASP isotopes are used in nuclear fuel and in the development of new nuclear technologies.
• Other industries: ASP isotopes are also used in a variety of other industries, such as aerospace, defense, and environmental remediation.

ASPI is still in the early stages of development, but the company has made significant progress in recent years. In 2022, ASP raised $9.1 million in a private placement of common stock. The company also announced plans to build a new isotope production facility in the United States.

ASPI's stock is traded on the Nasdaq stock exchange under the ticker symbol "ASPI." The company's stock price has been volatile in recent months, but it has trended upward overall.

Here is a summary of ASP Isotopes Inc. (ASPI):

• Industry: Advanced materials
• Sector: Technology
• Ticker symbol: ASPI
• Exchange: Nasdaq
• Market capitalization: $128.2 million (as of 2023-11-12)
• Business model: ASP produces high value and low volume isotopes for medical, nuclear power, and other industries.
• Growth prospects: ASP is still in the early stages of development, but the company has made significant progress in recent years. The company is building a new isotope production facility in the United States, and it has raised significant funding to support its growth.
• Risks: ASP is a pre-commercial stage company, and there is no guarantee that it will be successful in commercializing its products. The company also faces competition from other isotope producers.

Overall, ASP Isotopes Inc. is a high-growth company with a significant addressable market. The company is still in the early stages of development, but it has made significant progress in recent years. Investors who are willing to tolerate risk may want to consider investing in ASP.